![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: McGeer E.G. McGeer P.L.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.55, Iss.6, 1998-06, pp. : 739-746
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rotamase inhibitors for neurological diseases
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Role of GABA Analogues in the Treatment of Neurological Diseases
Current Medicinal Chemistry, Vol. 17, Iss. 22, 2010-08 ,pp. :